| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 311.0 | 287.3 | 274.7 |
| Other income | 8.1 | 5.4 | 7.7 |
| Total income | 319.1 | 292.7 | 282.4 |
| Profit before exceptional items & tax | 41.0 | 42.6 | 39.4 |
| Profit before tax | 41.0 | 42.6 | 39.4 |
| Net profit | 31.1 | 31.4 | 30.0 |
| Operating margin | 12.8% | 14.6% | 14.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +3.70% |
|---|---|
| Net profit, quarter on quarter | -1.00% |
| Revenue, year on year | +13.20% |
| Operating profit, year on year | +3.80% |
| Operating profit, quarter on quarter | -11.60% |
BSE results filing, NSE: ARTEMISMED. Figures extracted from the filing.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹293.20
- Market cap
- ₹4,642 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 40.8×Sector 52.3×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Other Announcement
Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.
Artemis Medicare Services Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 31,104 Lacs (+13.2% YoY); adj. EBITDA INR 7,150 Lacs (+22.7%, 23.3% margin); PAT INR 3,110 Lacs (+3.7%). Raipur ramp-up dilutes reported margins.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.
Artemis Medicare Services Other Announcement
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Artemis Medicare Services Legal & Regulatory
Artemis Medicare received a Rs. 11.11 Crore Show Cause Notice from the GST department. The company is contesting this through a writ petition.
- Value
- ₹11.11 Cr